Vetsys Pharmaceutical
Vetsys Pharmaceutical
The global Marine Collagen industry is currently witnessing an unprecedented surge, driven by the increasing consumer shift toward sustainable and ethical sources of protein. Unlike bovine or porcine collagen, marine collagen is extracted from fish scales and skin, making it a preferred choice for pescatarians and those concerned with environmental footprints. As of 2024, the market valuation is expanding at a CAGR of over 8%, fueled by the beauty-from-within movement and the rising aging population globally.
Industrial applications have expanded far beyond simple dietary supplements. High-purity marine collagen peptides are now integral to medical-grade wound dressings, tissue engineering, and advanced nutricosmetics. Manufacturers in China have positioned themselves at the epicenter of this supply chain, utilizing advanced enzymatic hydrolysis technology to produce low-molecular-weight peptides that ensure maximum bioavailability and rapid absorption.
Technological innovation is the primary differentiator in today's market. Leading manufacturers are moving away from traditional extraction methods toward Bio-Enzymatic Cleaving, which preserves the structural integrity of the amino acids. This transition ensures that the final product remains odorless, colorless, and highly soluble—key requirements for global beverage and skincare brands seeking premium ingredients.
Global buyers are demanding 100% traceability. From the ocean source to the final powder, "Clean Label" products that are non-GMO, hormone-free, and antibiotic-free are dominating the procurement lists of major retail chains in North America and Europe.
The trend is moving toward "Collagen Plus." Procurement demands now focus on synergistic formulations involving Sodium Hyaluronate, Vitamin C, and Biotin, creating a comprehensive solution for hair, skin, and nail health in a single dose.
Procurement teams are prioritizing manufacturers with strong ESG (Environmental, Social, and Governance) profiles. Utilizing by-products from the fishing industry to create high-value collagen exemplifies the circular economy that modern brands want to support.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the pharmaceutical and biotech industry with a registered capital of 30 million RMB. Our heritage in rigorous pharmaceutical manufacturing provides us with a unique advantage in the marine collagen sector: we apply medical-grade standards to every batch of nutritional supplements we produce.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become a powerhouse in the industry, achieving annual sales of over USD 20 million in the domestic market by 2015. Our facility includes specialized workshops for producing a wide range of products, including powders, premixes, injections, oral solutions, tablets, and advanced herbal drug extracts.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for both human health and animal wellness.
Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in global healthcare. Whether it's optimizing the molecular weight of hydrolyzed collagen or developing new botanical delivery systems, our R&D team is dedicated to excellence.
Quality is the cornerstone of our operations. We adhere to rigorous GMP standards, ensuring that all products undergo extensive quality control checks before reaching the market. Below is a glimpse into our diverse manufacturing capabilities:
Mold Injection
Welding
Assembly
Packaging
Injection Molding
Blow Molding
Extrusion Molding
Cotton Swab Processing
As a leading China manufacturer, we offer the economies of scale that European or American factories simply cannot match. By centralizing raw material sourcing and utilizing automated production lines, we provide competitive pricing without compromising on purity.
From custom formulation to final packaging design, our team handles the entire lifecycle of your product. Our "One-Stop" approach reduces lead times and ensures that your brand can enter the market faster.
Vetsys is actively exploring international expansion. We understand the regulatory hurdles of different regions, including FDA, EFSA, and local health department requirements, making us a reliable partner for global distribution.
Vetsys is committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are not only designed for efficacy but also to promote the overall well-being of both consumers and the planet.
Our Vision: At Vetsys, we are driven by our mission to improve global health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of biotech and healthcare.
